VERRICA PHARMACEUTICALS INC (VRCA) Stock Income Statement
USA - NASDAQ:VRCA - US92511W2070 - Common Stock
3.93 USD
+0.06 (+1.55%)
4.1 USD
+0.17 (+4.33%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.70M | 7.57M | 5.12M | 9.03M | 12.00M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 2.00M | 2.74M | 750.00K | 730.00K | null | |||
| Gross Profit | 12.71M | 4.83M | 4.38M | 8.31M | null | |||
| Operating Expenses | 51.92M | 70.18M | 67.71M | 29.60M | 42.91M | |||
| Research and Development | 7.70M | 11.84M | 20.30M | 12.20M | 15.93M | |||
| Selling, General, and Administrative Expenses | 43.58M | 59.00M | 47.00M | 17.41M | 26.98M | |||
| Operating Income | -38.54M | -65.92M | -63.46M | -21.29M | -30.91M | |||
| Interest Income/Expense | -9.86M | -10.64M | -1.22M | -1.70M | -4.17M | |||
| Other Income/Expense | 0 | -20.00K | -10.00K | -60.00K | null | |||
| Non Recurring Items | null | -80.00K | -2.54M | -1.44M | null | |||
| Income Before Taxes | -48.54M | -77.00M | -67.00M | -24.49M | -35.08M | |||
| Income Tax | null | 0 | null | 0 | null | |||
| Net Income | -48.54M | -77.00M | -67.00M | -24.49M | -35.08M | |||
| EBITDA | -37.84M | -64.96M | -62.91M | -20.84M | -30.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.29 | -14.86 | -14.77 | -7.16 | -12.97 | |||
| Non GAAP EPS | -8.280000000000001 | -11.44 | -1.46 | -0.79 | -1.29 | |||
| Statistics | ||||||||
| Gross Profit Margin | 86.46% | 63.79% | 85.44% | 92.03% | N/A | |||
| Profit Margin | -330.11% | -1017.71% | -1307.57% | -271.21% | -292.33% | |||
| Operating Profit Margin | -262.11% | -871.27% | -1238.49% | -235.77% | -257.58% | |||
All data in USD